1. Home
  2. AREC vs CVKD Comparison

AREC vs CVKD Comparison

Compare AREC & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREC
  • CVKD
  • Stock Information
  • Founded
  • AREC 2013
  • CVKD 2022
  • Country
  • AREC United States
  • CVKD United States
  • Employees
  • AREC N/A
  • CVKD N/A
  • Industry
  • AREC Coal Mining
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • AREC Energy
  • CVKD Health Care
  • Exchange
  • AREC Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • AREC 37.9M
  • CVKD 31.5M
  • IPO Year
  • AREC 2019
  • CVKD 2023
  • Fundamental
  • Price
  • AREC $1.29
  • CVKD $16.75
  • Analyst Decision
  • AREC Strong Buy
  • CVKD Strong Buy
  • Analyst Count
  • AREC 3
  • CVKD 1
  • Target Price
  • AREC $4.33
  • CVKD $32.00
  • AVG Volume (30 Days)
  • AREC 13.7M
  • CVKD 22.9K
  • Earning Date
  • AREC 05-20-2025
  • CVKD 05-08-2025
  • Dividend Yield
  • AREC N/A
  • CVKD N/A
  • EPS Growth
  • AREC N/A
  • CVKD N/A
  • EPS
  • AREC N/A
  • CVKD N/A
  • Revenue
  • AREC $399,962.00
  • CVKD N/A
  • Revenue This Year
  • AREC N/A
  • CVKD N/A
  • Revenue Next Year
  • AREC $3,208.62
  • CVKD N/A
  • P/E Ratio
  • AREC N/A
  • CVKD N/A
  • Revenue Growth
  • AREC N/A
  • CVKD N/A
  • 52 Week Low
  • AREC $0.38
  • CVKD $5.70
  • 52 Week High
  • AREC $1.68
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • AREC 83.81
  • CVKD 49.23
  • Support Level
  • AREC $0.38
  • CVKD $14.10
  • Resistance Level
  • AREC $0.92
  • CVKD $17.39
  • Average True Range (ATR)
  • AREC 0.16
  • CVKD 1.57
  • MACD
  • AREC 0.09
  • CVKD 0.04
  • Stochastic Oscillator
  • AREC 70.00
  • CVKD 54.19

About AREC American Resources Corporation

American Resources Corp is a next-generation, environmentally, and socially responsible supplier of high-quality raw materials to the new infrastructure market. The firm is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. The firm has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon and rare earth mineral deposits are concentrated. Its business model provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: